(Q36568989)

15 August 2017

1 reference

title

The potential of the tumor microenvironment to influence Apo2L/TRAIL induced apoptosis (English)

1 reference

15 August 2017

Thomas A Mace

1

1 reference

15 August 2017

Nariyuke Yamane

2

1 reference

15 August 2017

Jinrong Cheng

3

1 reference

15 August 2017

Bonnie L Hylander

4

1 reference

15 August 2017

Elizabeth A Repasky

5

1 reference

15 August 2017

1 January 2006

1 reference

Immunological Investigations

15 August 2017

1 reference

15 August 2017

35

1 reference

15 August 2017

279-296

1 reference

15 August 2017

3-4

1 reference

Targeting death and decoy receptors of the tumour-necrosis factor superfamily

15 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F08820130600745463

Death receptors: signaling and modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600745463

Stromal fibroblasts in cancer initiation and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600745463

TRAIL receptor-2 signals apoptosis through FADD and caspase-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600745463

Death to the bad guys: targeting cancer via Apo2L/TRAIL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600745463

Thermal regulation of lymphocyte trafficking: hot spots of the immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600745463

Tumor microvasculature as a barrier to antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600745463

MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600745463

21 January 2018

Inflammation and cancer

1 reference

https://api.crossref.org/works/10.1080%2F08820130600745463

Improving chemotherapeutic drug penetration in tumors by vascular targeting and barrier alteration

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600745463

Emerging non-apoptotic functions of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/Apo2L.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600745463

Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600745463

Caspase cleaved BID targets mitochondria and is required for cytochrome c release, while BCL-XL prevents this release but not tumor necrosis factor-R1/Fas death

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600745463

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600745463

The anti-tumor effect of Apo2L/TRAIL on patient pancreatic adenocarcinomas grown as xenografts in SCID mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600745463

The roles of IFN gamma in protection against tumor development and cancer immunoediting

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600745463

Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600745463

Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600745463

Deficient tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptor transport to the cell surface in human colon cancer cells selected for resistance to TRAIL-induced apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600745463

Matrix metalloproteinases in tumor invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600745463

Type I interferons (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells: A novel mechanism for the antitumor effects of type I IFNs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600745463

A novel in vitro model of human mesothelioma for studying tumor biology and apoptotic resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600745463

Hypoxia inhibits tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by blocking Bax translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600745463

Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600745463

Apo2L/TRAIL and its death and decoy receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600745463

Hypoxia and low glucose differentially augments TRAIL-induced apoptotic death

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600745463

Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600745463

Matrix metalloproteinase-1 associates with intracellular organelles and confers resistance to lamin A/C degradation during apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600745463

Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600745463

An MMP-2/MMP-9 inhibitor, 5a, enhances apoptosis induced by ligands of the TNF receptor superfamily in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600745463

An antagonist decoy receptor and a death domain-containing receptor for TRAIL

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600745463

Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600745463

Acceleration of human neutrophil apoptosis by TRAIL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600745463

Mutation analysis and mRNA expression of trail-receptors in human breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600745463

Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600745463

Nature's TRAIL--on a path to cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600745463

Endothelin-1 is a critical mediator of myogenic tone in tumor arterioles: implications for cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600745463

Caspase-10 is recruited to and activated at the native TRAIL and CD95 death-inducing signalling complexes in a FADD-dependent manner but can not functionally substitute caspase-8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600745463

The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600745463

How matrix metalloproteinases regulate cell behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600745463

Neovascular targeting chemotherapy: encapsulation of paclitaxel in cationic liposomes impairs functional tumor microvasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600745463

Critical role for tumor necrosis factor-related apoptosis-inducing ligand in immune surveillance against tumor development

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600745463

Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600745463

Growth factors in human ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600745463

Identification and characterization of a new member of the TNF family that induces apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600745463

Sustained low-level expression of interferon-gamma promotes tumor development: potential insights in tumor prevention and tumor immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600745463

10.1080/08820130600745463

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference